Study of Healthy Aging and Physical function with Elamipretide (SHAPE)
We have reported health benefits from a single dose elamipretide injection in older adults. The purpose of the SHAPE study is to better understand the effects and potential benefits of elamipretide on skeletal muscle, cognitive function, ad blood markers of aging in older adults. In addition, this study will serve as stepping-stone toward a larger scale clinical trial aimed at understanding how elamipretide may help enhance healthy aging. Elamipretide, the study drug, has FDA accelerated approval as Forzinity™ only for use in the treatment of patients with Barth syndrome in the US weighing ≥ 30 kg.
We are seeking individuals 65-80 yr who are free of chronic disease and are able to attend 2 baseline visits, 4-week daily injection of study drug, and 2 post interventional visits at Fred Hutchinson Cancer Center.
The study includes: a screening/baseline phase (two onsite visits), an intervention period (4 week daily injection of study drug), a mid-intervention check-in phone call, a post-intervention phase (two onsite visits), and a follow-up phase that includes a phone call approximately two weeks after your final visit.
You will be reimbursed $400 for completing the study and transportation costs will be covered
Location: Fred Hutchinson Cancer Center Prevention Center located at Level E of the Robert M, Arnold Building
Contact
Sophia Liu
206-543-0209